Dr. Huckfeldt is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Massachusetts Eye and Ear Infirmary
243 Charles Street
Boston, MA 02114Phone+1 617-573-3621
Education & Training
- Massachusetts Eye and Ear Infirmary/Harvard Medical SchoolResidency, Ophthalmology, 2010 - 2013
- Washington University in St. Louis School of MedicineClass of 2009, MD, PhD
- University of Iowa Hospitals and ClinicsFellowship, Medical Retina
- Newton-Wellesley HospitalInternship, Transitional Year
- University of PennsylvaniaPostdoctoral Research, Ophthalmology
- Massachusetts Eye and EarFellowship, Inherited Retinal Degenerations
Certifications & Licensure
- MA State Medical License 2015 - 2025
- IA State Medical License 2014 - 2016
- PA State Medical License 2013 - 2014
- American Board of Ophthalmology Ophthalmology
Clinical Trials
- Safety and Efficacy Trial of AAV Gene Therapy in Patients With CNGA3 Achromatopsia (A Clarity Clinical Trial) Start of enrollment: 2017 Aug 03
- Follow-up Gene Therapy Trial for the Treatment of X-linked Retinitis Pigmentosa Associated With Variants in the RPGR Gene Start of enrollment: 2020 Dec 04
Publications & Presentations
PubMed
- 13 citationsRNA-based therapies in inherited retinal diseases.Aniz Girach, Isabelle Audo, David G Birch, Rachel M Huckfeldt, Byron L Lam
Therapeutic Advances in Ophthalmology. 2022-11-04 - 11 citationsBiallelic RP1-associated retinal dystrophies: Expanding the mutational and clinical spectrum.Rachel M. Huckfeldt, Florin Grigorian, Emily Place, Jason Comander, Demetrios G. Vavvas
Molecular Vision. 2020-06-03 - 5 citationsGene editing technology: Towards precision medicine in inherited retinal diseases.Brian G. Ballios, Eric A. Pierce, Rachel M. Huckfeldt
Seminars in Ophthalmology. 2021-02-23
Press Mentions
- AGTC Reports 12-Month Data from Its Ongoing Phase 1/2 Achromatopsia Clinical Trials Showing Biologic Activity in Patients with Mutations in the ACHM B3 GeneJune 24th, 2021
- Foundation Fighting Blindness to Jointly Host Online Continuing Medical Education (CME, COPE) WebinarSeptember 24th, 2020
- Mass General Research Awards and Honors: October 2018November 15th, 2018
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: